Contemporary Use of Digoxin in the Management of Cardiovascular Disorders

This publication has 44 references indexed in Scilit:

• Executive Summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline
  Journal of Cardiac Failure, 2006
• Rehabilitating digoxinThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
  European Heart Journal, 2005
• The Polymorphonuclear Leukocyte and the Abdominal Aortic Aneurysm
  Circulation, 2005
• Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design
  American Heart Journal, 2004
• Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart Failure
  New England Journal of Medicine, 2002
• Digoxin
  Progress in Cardiovascular Diseases, 2002
• The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure
  New England Journal of Medicine, 1997
• Digoxin for chronic heart failure: A review of the randomized controlled trials with special attention to the PROVED and RADIANCE trials
  Progress in Cardiovascular Diseases, 1994
• Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial
  Journal of the American College of Cardiology, 1993
• Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors
  New England Journal of Medicine, 1993